Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Amorepacific Group is a major player in the global beauty and personal care industry, primarily involved in the development, manufacturing, and distribution of cosmetics, skincare, and haircare products. The company is renowned for its diverse portfolio of brands that include names such as Sulwhasoo, Laneige, Mamonde, and Innisfree, which cater to a broad range of demographics and price points. Amorepacific places a strong emphasis on research and development, utilizing advanced technologies to innovate in the fields of anti-aging, hydration, and skincare science. This focus on R&D helps to maintain its competitive edge within the dynamic beauty sector. Headquartered in Seoul, South Korea, Amorepacific has achieved global recognition, with a significant market presence across Asia, North America, and Europe. Its ongoing commitment to sustainability and social responsibility further enhances its brand reputation. As one of the leaders in the beauty market, Amorepacific continues to influence beauty standards and trends, driven by both traditional Korean beauty philosophies and contemporary consumer needs.
₩24,000.00
₩150.00 (-0.62%)
Live · 11:09 AM
Operating margin is thin at 7.96%. Limited cushion if revenue slows or costs rise, not the profile of a wide-moat business.
Revenue grew 8.5%, steady but not accelerating.
Even for strong businesses, today's 16x P/E means the stock needs to keep delivering. There's no margin of safety if growth disappoints.
16.0x earnings, 4.6x FCF. Valuation is in a reasonable range. The main question is whether the business can re-accelerate or if current trajectory is already priced in.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
₩4.68T
▲ +8.5% YoY
Net Income (TTM)
₩284.61B
▼ -55.3% YoY
Op. Margin
8.05%
▲ +2.1pp YoY
ROIC
3.62%
▲ +0.3pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
₩473.53B
▲ +95.1% YoY
Op. Cash Flow (TTM)
₩572.52B
▲ +11.4% YoY
Net Debt
-₩1.51T
Net Cash Position
Cash & Equiv.
₩1.86T
3Y CAGR: +0.9%
3Y CAGR: +182.7%
Continue Research
At a P/E of 16.0 and a price-to-free-cash-flow of 4.6, Amorepacific (002790.XKRX) trades below a two-stage DCF intrinsic value of about KRW 107,312.18 per share, so at KRW 24,000.00 the stock looks undervalued (347.1% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Amorepacific scores 73/100 on Intrinsiqq's quality scorecard (a solid business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 4.5%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about KRW 107,312.18 per share for 002790.XKRX, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around KRW 80,484.14. At today's KRW 24,000.00, that puts the stock about 347.1% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Amorepacific scores 73 out of 100 on Intrinsiqq's quality score, a weighted blend of 8 metrics each scored 0 to 100, which makes it a solid business on these measures. Recent fundamentals include a 8.1% operating margin and a 3.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Amorepacific pays a regular dividend of about KRW 1,082.27 per share per year (typically in quarterly installments), a yield of roughly 4.5% at the current price. That is a payout ratio of about 34.4% of earnings, so the dividend is amply covered by earnings. Amorepacific has grown the dividend at roughly 12.6% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For 002790.XKRX's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. 002790.XKRX currently trades below its estimated intrinsic value and scores 73/100 on quality (solid). It also yields about 4.5%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.